Abstract
Given the high rates of morbidity and mortality from cardiovascular disease (CVD), the primary and secondary CVD prevention is one of the public health priority. Inflammation and endothelial dysfunction are the major drivers of atherosclerosis development and progression. In this regard, the study of the biomarker application as a tool to better identify high-risk individuals is an up-to-date sector of modern cardiology. The simultaneous measurement of multiple biomarkers can increase the risk stratification for people who are not known to have cardiovascular events in their history. The study aimed to investigate the predictive value of chemokine (C-X-C motif) ligand 16 (CXCL16), endocan, and heart-type fatty acid binding protein (H-FABP) in the cardiovascular event development in people who are not known to have cardiovascular events in their history. We examined 363 people aged 30 to 65 who have been living permanently in the city of Saran, Karaganda region. The selected participants were people registered at a clinic at the city of Saran, who were screened between August and September 2014. The follow-up period was 48 months (from August-September 2014 to November 2018). The results showed that CXCL16 (p < 0.001), endocan (...Continue Reading
References
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D BéchardP Lassalle
Mar 29, 2007·Archives of Internal Medicine·Atsushi HozawaLloyd E Chambless
Aug 28, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi NiizekiIsao Kubota
Jul 14, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ke-di WangXi-xiong Kang
Dec 24, 2010·Cytokine·Gui-wen YiYu-cheng Zhong
Apr 5, 2014·Archives of Medical Science : AMS·Aijun MaCuiling Ma
May 23, 2014·PloS One·Yoichiro OtakiIsao Kubota
Jul 6, 2014·Kidney International·Mahmut I YilmazMehmet Kanbay
Aug 26, 2014·International Journal of Cardiology·Koichi SetsutaKyoichi Mizuno
Aug 30, 2014·Angiology·Murat KoseTufan Tukek
Dec 10, 2015·Atherosclerosis·Lars E LaugsandThor Ueland
May 15, 2016·Angiology·Harun KundiEnder Ornek
May 16, 2017·The American Journal of the Medical Sciences·Yaya LvJinxing Quan
Jun 21, 2017·American Journal of Nephrology·Wenjin LiuJunwei Yang
Sep 16, 2017·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yoichiro OtakiIsao Kubota
Sep 28, 2018·Scientific Reports·Sing-Kong HoJaw-Wen Chen
Dec 14, 2018·Medicine·Tianming ZhaoJixiang Ni